V. Craig Jordan, PhD, the groundbreaking pharmacologist often called the “father” of breast most cancers drug Tamoxifen, died just lately at 76. Jordan, who was professor of Molecular Pharmacology at Feinberg from 1993–2004, was the primary to find selective estrogen receptor modulators and deploy the therapy in breast most cancers.
His analysis confirmed that Tamoxifen, a drug initially designed to dam the results of estrogen and forestall being pregnant, might additionally arrest most cancers cell development. The drug has since turn into some of the extensively used remedies in opposition to breast most cancers and is on the World Well being Group’s checklist of important medicines.
Tamoxifen, together with different selective estrogen receptor modulators, are credited with serving to tens of millions of individuals world wide.
Throughout his time at Feinberg, Jordan was additionally the inaugural Diana Princess of Wales Professor of Most cancers Analysis (2000-2004), and director of the Lynn Sage Most cancers Analysis Program on the Robert H. Lurie Most cancers Heart of Northwestern College.
Jordan acquired many awards and accolades for his work, together with being appointed an Officer of the Most Glorious Order of the British Empire (OBE) by Queen Elizabeth in 2002. He was elected to the Nationwide Academy of Sciences in 2009 and the Nationwide Academy of Medication in 2017. In 2019, he was named a Companion of the Order of St Michael and St George for providers to girls’s healthcare.
Most just lately, Jordan served as professor of Breast Medical Oncology and Molecular and Mobile Oncology at The College of Texas MD Anderson Most cancers Heart.
Jordan is survived by two daughters and 5 grandchildren.
